Analytical Data
-
Gene name
MCTS1
- Application
-
Alternative Names
Multiple copies T-cell malignancies
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9ULC4
-
Expression Region
1-181aa
-
Molecular Weight
36.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MCTS1 (Melanoma Classroom Tumor Suppressor 1) is a protein that plays a significant role in cellular processes related to tumor suppression, particularly in melanoma. Research into MCTS1 has gained momentum as understanding its function and mechanisms can provide critical insights into cancer biology and potential therapeutic strategies. Studies have revealed that MCTS1 may influence various cellular pathways, including apoptosis, cell proliferation, and migration, which are fundamental to tumor development and progression. Additionally, aberrations in the expression or function of MCTS1 have been linked to the malignancy of melanoma, prompting scientists to explore its potential as a biomarker for diagnosis or prognosis. The recombinant expression of MCTS1 allows researchers to study its properties in detail, assess its interactions with other proteins, and evaluate its role in the development of cancer therapies. By harnessing advances in molecular biology and protein engineering, the investigation of MCTS1 can potentially lead to novel approaches for combating melanoma and other related malignancies, highlighting the importance of this protein in the continuing efforts to understand cancer at the molecular level. Understanding the functional characteristics of MCTS1 could pave the way for innovative drug development and personalized medicine strategies in oncology.
